Last reviewed · How we verify

NCT03960307

Glycocalyx and Microcirculation in Sepsis

Completed Last updated 8 September 2023
What this trial tests

trial testing Microcirculation and Glycocalyx assessment in Sepsis in 40 participants. Completed in 30 September 2017.

Timeline
1 July 2017
Primary endpoint
30 September 2017
30 September 2017

Quick facts

Lead sponsorUniversity Hospital Muenster
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 July 2017
Primary completion30 September 2017
Estimated completion30 September 2017
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Muenster

Who can join

Eligibility, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observative, prospective study with cross-sectional design is to explore possible correlations/associations between microcirculation parameters and sublingual endothelial glycocalyx in sepsis. Therefore, 30 critically ill septic patients and 10 healthy controls were enrolled.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis.
    Rovas A, Seidel LM, Vink H, Pohlkötter T, et al · · 2019 · cited 88× · PMID 31340868 · DOI 10.1186/s13054-019-2542-2

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other University Hospital Muenster trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03960307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing